The UroLift® System

Treatment with the UroLift® System is typically a one-time solution that provides rapid relief and recovery for men living with symptoms of an enlarged prostate.1

It breaks the cycle of medications and how they make a person feel.2

Learn More

Why Choose UroLift®?

The proven, minimally invasive treatment that fills the gap between prescription medications and more invasive surgical procedures.

  • Rapid symptom relief and recovery3,4

  • Lowest catheter rate among leading BPH procedures1,3,5-8

  • No new onset, sustained erectile or ejaculatory dysfunction4

  • Proven durability through five years1

The Prostatic Urethral Lift (PUL) procedure (using the UroLift® System) is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines.

The UroLift® System treatment delivers a positive patient experience

350,000*

No. of patients who have been treated with the UroLift® System globally as of Jun 2022

Compare With Other Treatments

Hear From Other Urologists**

  • Dr. Ronny Tan

    MBBS (Singapore), MRCSEd, MMed (Surgery), FAMS (Urology)

    The UroLift® system has given me the opportunity to treat men with BPH who are seeking to preserve their sexual function.***1 These men previously would potentially be using medical therapy,...See more

    The UroLift® system has given me the opportunity to treat men with BPH who are seeking to preserve their sexual function.***1 These men previously would potentially be using medical therapy, in many cases with its attendant side effects. I have found that the UroLift® system can provide quick relief of urinary symptoms with a low risk of permanent side effects with improvement as early as two weeks, and is a welcome addition to our surgical armamentarium for BPH.1,3,4

  • Dr. Lincoln Tan

    MBBS (Singapore), MRCSEd, MMed (Surgery), FRCS (Urology)(RCPSG), FAMS (Urology)

    Ejaculatory dysfunction has always been an unspoken issue for the longest time for patients undergoing treatment for BPH, be it medical or surgical treatment. With the arrival of UroLift®, as...See more

    Ejaculatory dysfunction has always been an unspoken issue for the longest time for patients undergoing treatment for BPH, be it medical or surgical treatment. With the arrival of UroLift®, as an andrologist, whenever I see a sexually active man who is embarking on the treatment for BPH, my aim now is to improve his urinary flow with less risk of compromise to his sexual function, whenever possible.***1,2,6 I strongly believe that adding UroLift® to the armamentarium of the treatment options for BPH, we can now treat with less risk to ejaculatory and erectile function,***1,2,6 help preserve bladder function in the long run,9 and can get more men off of medication,1 decreasing the possibility of non-compliance to BPH medications.10

View Clinical Results

Talk to Your Patient About the UroLift® System Today

Patients who seek medical advice might not be fully aware of the treatment options available to them and will need appropriate information and time to make a decision. Providing materials explaining their options, that they can bring home to discuss with their loved ones will be beneficial.

Download Patient Info Booklet

Not all products shown on the website may be approved in all regulatory jurisdictions. Consult with your local Teleflex representative for details.
Consult the Instructions for Use (IFU) for more information.
The information contained on this website is intended only for health care professionals in Singapore.

* Management estimate based on product sales and average units per procedure.
** As with any medical procedure, individual results may vary.
***No instances of new onset, sustained erectile or ejaculatory dysfunction in the LIFT pivotal study

References

1.

Roehrborn et al. Can J Urol 2017

2.

AUA Guidelines 2003, 2020

3.

Shore, Can J Urol 2014

4.

Roehrborn, J Urology 2013

5.

Bachmann, Eur Urol 2014 May

6.

McVary, J Urol 2016

7.

Mollengarden, Prostate Cancer Prostatic Dis 2018

8.

Gilling, J Urol 2017

9.

Tubaro, Drugs Aging 2003

10.

NeoTract US Market Model estimates for 2020 based on IQVIA data, data on file

Healthcare Professional Confirmation

The information on the page you are about to enter is intended for Healthcare Professionals only.
By clicking the box below, you confirm that you are a Healthcare Professional.

Continue